Navigation Links
Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
Date:2/6/2008

ancial results while successfully integrating a major acquisition. I want to thank our employees around the world for working hard to meet aggressive goals across our businesses. Armed with an unmatched portfolio of offerings, we are well- equipped to meet the needs of our customers in all our major end markets, from life sciences and healthcare to industrial, environmental and safety."

Mr. Dekkers added, "Looking ahead to 2008, we expect adjusted EPS to be in the range of $3.05 to $3.15. This would lead to adjusted EPS growth of 15 to 19% over our strong performance in 2007. We expect to achieve 2008 revenues of $10.5 to $10.6 billion, resulting in 8 to 9% revenue growth over our 2007 results." (The 2008 guidance does not include any future acquisitions or divestitures, and is based on present currency exchange rates. In addition, the adjusted EPS estimate excludes amortization expense for acquisition- related intangible assets and certain other items detailed later in this press release under the heading "Use of Non-GAAP Financial Measures.")

Management uses adjusted operating results to monitor and evaluate performance of the company's business segments. Results in the following segment information are reported on a pro forma adjusted basis for 2006, as if Thermo and Fisher had been combined for the entire year.

Analytical Technologies Segment

Revenues in the Analytical Technologies Segment grew 14% in the fourth quarter of 2007 to $1.17 billion, compared with pro forma 2006 revenues of $1.02 billion. Operating income increased 33% in the fourth quarter of 2007, and operating margin rose to 21.0%, versus pro forma 2006 results of 17.9%.

For the full year, pro forma segment revenues grew 14% to $4.26 billion in 2007, compared with $3.74 billion in 2006. Pro forma adjusted operating income for the segment grew 31% in 2007, and pro forma adjusted operating margin increased to 19.8%, versus 17.2% a year ago.

Laboratory Produc
'/>"/>

SOURCE Thermo Fisher Scientific Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related biology technology :

1. Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs
2. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
3. Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
4. Thermo Fisher Scientific to Present at the 26th Annual JPMorgan Healthcare Conference
5. Thermo Fisher Scientific Acquires Leading Chromatography Consumables Provider, La-Pha-Pack
6. Thermo Fisher Scientific Selected by China Doping Control Center to Supply Testing Instrumentation for the 2008 Olympic Games in Beijing
7. MIT: Thermoelectric materials are 1 key to energy savings
8. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
9. Thermo Fisher Scientific Reports Record Third Quarter Revenues and Adjusted EPS and Raises Full-Year Guidance
10. Thermo Fisher Scientific to Expand Manufacturing Operation for Single-Use Bioprocessing Containers
11. Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014 Amgen (NASDAQ: AMGN ) ... $0.61 per share dividend for the third quarter of ... 2014, to all stockholders of record as of the ... About Amgen Amgen is committed to unlocking the ... by discovering, developing, manufacturing and delivering innovative human therapeutics. ...
(Date:7/25/2014)... 2014 According to a new market ... - Global Industry Analysis, Size, Share, Growth, Trends and ... is estimated at USD 161,056.5 million in 2014 and ... from 2014 to 2020, to reach an estimated value ... drugs market is witnessing a significant growth due to ...
(Date:7/25/2014)... 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... development and commercialization of a once-daily, oral therapy for ... announced financial results for the period ended June 30, ... , Reported cash and cash equivalents totaling $37.4 million ... 31, 2013.  , Reported a net loss of ...
(Date:7/24/2014)... NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. ... the long-term, randomized, active control Phase 3 study of ... phosphate binder, for the treatment of hyperphosphatemia in patients ... study (PhosphatE binding and iRon delivery with FErric CiTrate ... Journal of the American Society of Nephrology ( ...
Breaking Biology Technology:Amgen Announces 2014 Third Quarter Dividend 2Amgen Announces 2014 Third Quarter Dividend 3Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4
... of Wisconsin-Milwaukee (UWM) have discovered an entirely new ... kid" of the carbon family, graphene. The discovery, ... pushes carbon materials closer to ushering in next-generation ... that resembles a flat sheet of chicken wire ...
... Calif., April 16, 2012 WaferGen Bio-systems, Inc. ... a strategic realignment and new direction for the ... customers to perform accurate high-throughput qPCR projects for ... sequencing in a simpler and more cost-effective way.  ...
... MOORESVILLE, N.C., April 13, 2012 A recent solicitation ... Iosat Potassium Iodide has created a deluge of orders ... for troop support, the 130mg tablets provide protection against ... International concerns about the development of nuclear weaponry in ...
Cached Biology Technology:UWM discovery advances graphene-based electronics 2UWM discovery advances graphene-based electronics 3WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment 2WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment 3Potassium Iodide Sales Surge on Heels of Large Government Order 2
(Date:7/28/2014)... DUBLIN , July 28, 2014 ... the "Biometrics Market in Latin America 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Biometrics measure and analyze biological ... facial patterns, irises, eye retinas, voice patterns, and hand ... one or more stored templates. The main purpose of ...
(Date:7/28/2014)... Engineering at Harvard University today announced that its ... newly formed private company to accelerate development of ... The announcement follows a worldwide license agreement ... the start-up Emulate Inc., relating to the use ... , "This is a big win towards achieving ...
(Date:7/27/2014)... has revealed that nicotine and cotinine, a metabolite of ... certain carcinogen in smoke. , The carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or ... and ultimately ends up in the tobacco smoke. Once ... where it is activated by a variety of enzymes ... revealed that nicotine can partially interfere with the activation ...
Breaking Biology News(10 mins):Biometrics Market in Latin America 2014-2018 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 3Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2
... climate change, researchers at BBSRC-supported Rothamsted Research have shown. ... aphid (Myzus persicae) has been found to be flying ... for January and February combined. This year, the first ... weeks ahead of the 42-year average. This work is ...
... the hundreds of species of woody vines that University of ... of Panama, the largest has a stalk nearly 20 inches ... Schnitzer. "And because it winds itself up to the forest ... as a community of trees." Such vines, called lianas, ...
... health care, computational biology, homeland security and other areas, ... proven cumbersome and difficult. An emerging research field known ... such mountains of information to find and put together ... of Technology has received a five-year grant to lead ...
Cached Biology News:Aphids are sentinels of climate change 2Vine invasion? UWM ecologist looks at coexistence of trees and lianas 2Vine invasion? UWM ecologist looks at coexistence of trees and lianas 3Grant supports emerging field of massive data analysis and visual analytics 2Grant supports emerging field of massive data analysis and visual analytics 3Grant supports emerging field of massive data analysis and visual analytics 4
... Cell Invasion Assay is designed to determine ... as a significant barrier to invasion or ... in a convenient, high-throughput, 96-well format. The ... all types of adherent cells such as ...
... design in ice/water bath This CLS ... created to easily match Cornings product ... please order under the old Sigma-Aldrich ... for assistance. ID clarifier: rack and ...
Membrane Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
Biology Products: